Publications by authors named "RH Ritchie"

Claim this Profile
F
Formylpeptide receptors: A novel target to treat cardiometabolic complications.
Chen Huei Leo, Elizabeth A Vecchio, Ting Fu, Xiangyan Yi, Cheng Peng, Rebecca H Ritchie

Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury.
Andrew R Kompa, David W Greening, Jarmon G Lees, Anne M Kong, Jonathon Cross, Rebecca H Ritchie

Stem Cell Res Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for diet-induced models of cardiometabolic syndrome.
Timothy M Sveeggen, Pooneh Bagher, Hiroe Toba, Merry L Lindsey, Rebecca H Ritchie

Am J Physiol Heart Circ Physiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of diet-induced obesity and voluntary exercise training on cardiac lipids and mitochondrial function in mice.
Nimna Perera, Minh Deo, Surafel Tegegne, Yow Keat Tham, Natalie A Mellett, Rebecca H Ritchie

J Sport Health Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MitoQ Protects Against Oxidative Stress-Induced Mitochondrial Dysregulation in Human Cardiomyocytes.
Alex M Parker, Jarmon G Lees, Mitchel Tate, Ren J Phang, Anida Velagic, Rebecca H Ritchie

J Mol Cell Cardiol Plus· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine: Therapeutically Targeting Mitochondrial Alterations in Heart Failure.
Alex M Parker, Jarmon G Lees, Andrew J Murray, Anida Velagic, Shiang Y Lim, Rebecca H Ritchie

JACC Basic Transl Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in mice.
Jaideep Singh, Kristy L Jackson, Haoyun Fang, Feng Shii Tang, Cindy Gueguen, Rebecca H Ritchie

Commun Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in incretin therapies for targeting cardiovascular disease in diabetes.
Timothy D Roberts, Dana S Hutchinson, Denise Wootten, Miles J De Blasio, Rebecca H Ritchie

J Mol Cell Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.
Cheng Peng, Elizabeth A Vecchio, Anh T N Nguyen, Mia De Seram, Ruby Tang, Rebecca H Ritchie

Br J Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoxin A improves cardiac remodeling and function in diabetes-associated cardiac dysfunction.
Ting Fu, Muthukumar Mohan, Madhura Bose, Eoin P Brennan, Helen Kiriazis, Rebecca H Ritchie

Cardiovasc Diabetol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage.
Jaideep Singh, Kristy L Jackson, Haoyun Fang, Audrey Gumanti, Bethany Claridge, Rebecca H Ritchie

Cardiovasc Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting G protein-coupled receptors for heart failure treatment.
Bui San Thai, Ling Yeong Chia, Anh T N Nguyen, Chengxue Qin, Rebecca H Ritchie

Br J Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices.
William R Studley, Emma Lamanna, Katherine A Martin, Claudia A Nold-Petry, Simon G Royce, Rebecca H Ritchie

Br J Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy.
Kimberley M Mellor, Upasna Varma, Parisa Koutsifeli, Lorna J Daniels, Victoria L Benson, Rebecca H Ritchie

J Mol Cell Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists.
Xiangyan Yi, Eric Tran, Jephthah O Odiba, Cheng Xue Qin, Rebecca H Ritchie

Eur J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling.
Jaideep Singh, Kristy L Jackson, Feng Shii Tang, Ting Fu, Cameron Nowell, Rebecca H Ritchie

FASEB J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targets of fibrosis: Translational advances and current challenges.
Miles J De Blasio, Eliot H Ohlstein, Rebecca H Ritchie

Br J Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy.
Charles D Cohen, Miles J De Blasio, Gabriella E Farrugia, Malathi S I Dona, Ian Hsu, Rebecca H Ritchie

iScience· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice.
Chen Huei Leo, Jamie Li Min Ou, Eng Shi Ong, Cheng Xue Qin, Rebecca H Ritchie

Biomed Pharmacother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries.
Maria Jelinic, Kristy L Jackson, Kelly O'Sullivan, Jaideep Singh, Thomas Giddy, Rebecca H Ritchie

Life Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities.
Arpeeta Sharma, Judy S Y Choi, Anna M D Watson, Leila Li, Thomas Sonntag, Rebecca H Ritchie

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study.
Abhipree Sharma, Stephen Wood, J Simon Bell, Miles J De Blasio, Jenni Ilomäki, Rebecca H Ritchie

Lancet Reg Health West Pac· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.
Anida Velagic, Mandy Li, Minh Deo, Jasmin Chendi Li, Helen Kiriazis, Rebecca H Ritchie

Am J Physiol Heart Circ Physiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery.
Lauren T May, Belinda A Bartolo, David G Harrison, Tomasz Guzik, Grant R Drummond, Rebecca H Ritchie

Clin Sci (Lond)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
Bianca C Bernardo, Gunes S Yildiz, Helen Kiriazis, Claudia A Harmawan, Celeste M K Tai, Rebecca H Ritchie

Cells· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis